Published 2 days ago • loading... • Updated 2 days ago

Novartis’ Zolgensma sales fall again as gene therapy market woes persist

Novartis has seen sales decline in a difficult gene therapy market. Is there hope on the horizon?

Novartis has seen sales decline in a difficult gene therapy market. Is there hope on the horizon?

2 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated21 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news in 2 days ago on Tuesday, July 22, 2025.

Sources are mostly out of (0)